Phenotypeca Announces Commencement Of Lab 4.0 ProjectGemma Cann2024-11-28T15:16:33+00:00February 4th, 2022|BioCity Nottingham, News|
Sygnature Discovery Appoints Dr Charles Woler As ChairmanGemma Cann2024-11-28T15:17:03+00:00January 14th, 2022|BioCity Nottingham, News|
NuVision Biotherapies Announces The Appointment Of New CEO And COOGemma Cann2024-11-28T15:30:12+00:00January 14th, 2022|MediCity Nottingham, News|
Symrise Opens Innovation Lab Located At Colworth Science ParkGemma Cann2024-11-28T15:21:14+00:00December 15th, 2021|Colworth Park, News|
New CFO Jordison Steps Up At Sygnature DiscoveryGemma Cann2024-11-28T15:19:23+00:00December 8th, 2021|BioCity Nottingham, News|
Award Winning Business Helping to Combat Deadliest DiseasesGemma Cann2023-09-04T12:54:30+01:00November 29th, 2021|News, Wilton Centre|
Why The Pioneer Group Accelerator Programme Wants To Help You Get it WrongGemma Cann2024-11-28T14:10:12+00:00November 19th, 2021|Accelerator, Article|
Wilton Centre Welcomes Launch Of Teesside FreeportGemma Cann2024-11-28T16:54:18+00:00October 28th, 2021|News, Wilton Centre|
Pioneer Group Announce New Life Sciences And Acceleration Facility At The Campus, CherrywoodGemma Cann2024-11-28T15:20:43+00:00October 6th, 2021|Accelerator, Cherrywood, News|
MIP Diagnostics Secures £5.1m In Funding To Expand Commercial Operations And ProductionGemma Cann2024-11-28T15:23:16+00:00August 25th, 2021|Colworth Park, News|
